Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Isoamyl 4-methoxycinnamate
2. Isopentyl P-methoxycinnamate
3. Amiloxate [usan]
4. Isoamyl Methoxycinnamate
5. Amiloxato
6. Nsc-408332
7. 376ktp06k8
8. Amiloxate [inn]
9. Amiloxate [mi]
10. E-1000
11. 4-methoxycinnamic Acid, Isoamyl Ester
12. Amiloxate [mart.]
13. Amiloxate [usp-rs]
14. Amiloxate [who-dd]
15. Amiloxate [usp Impurity]
16. Dtxcid9026055
17. Dtxsid1046055
18. Amiloxate [usp Monograph]
19. Nsc408332
20. Amiloxate (mart.)
21. Amiloxate (usp-rs)
22. 3-methylbutyl (2e)-3-(4-methoxyphenyl)prop-2-enoate
23. Amiloxate (usp Impurity)
24. Amiloxate (usp Monograph)
25. Amiloxatum
26. Refchem:557171
27. 2-propenoic Acid, 3-(4-methoxyphenyl)-, 3-methylbutyl Ester
28. Isopentyl 3-(4-methoxyphenyl)acrylate
29. Isopentyl-4-methoxycinnamate
30. Isopentyl 4-methoxycinnamate
31. Isoamyl-p-methoxycinnamate
32. 155339-66-5
33. 3-methylbutyl (e)-3-(4-methoxyphenyl)prop-2-enoate
34. Mfcd00583856
35. Ncgc00159435-02
36. 3-(4-methoxyphenyl)-2-propenoic Acid, 3-methylbutyl Ester
37. (e)-isopentyl 3-(4-methoxyphenyl)acrylate
38. 3-methylbutyl 3-(4-methoxyphenyl)prop-2-enoate
39. Neo Heliopan E1000
40. Amiloxate [usan:usp:inn]
41. Unii-376ktp06k8
42. Einecs 275-702-5
43. Neo Heliopan (tn)
44. Brn 3132627
45. Amiloxate (usp/inn)
46. Ai3-05552
47. 96% (isomers Mixture)
48. E 1000
49. Ec 275-702-5
50. 3-methylbutyl 3-(4-methoxyphenyl)-2-propenoate
51. Schembl15764
52. 3-10-00-00850 (beilstein Handbook Reference)
53. Chembl1476782
54. 3-(4-methoxyphenyl)-2-propenoic Acid 3-methylbutyl Ester
55. Msk3423
56. Chebi:135982
57. Ubnyrxmkiigmkk-rmknxtfcsa-n
58. Dtxsid301349309
59. 4-methoxycinnamic Acid-isoamyl Ester
60. Tox21_111666
61. S3218
62. Akos015913998
63. Akos025310783
64. Cs-w012670
65. Db11207
66. Fi29838
67. Hy-w011954
68. Nsc 408332
69. Ncgc00159435-03
70. Bs-49548
71. Da-54393
72. Cas-71617-10-2
73. D02904
74. D91203
75. Isoamyl 4-methoxycinnamate, Analytical Standard
76. Sbi-0654197.0001
77. En300-7363198
78. Isopentyl (e)-3-(4-methoxyphenyl)prop-2-enoate
79. 617i102
80. En300-18004835
81. Sr-01000201509
82. Sr-01000201509-1
83. 3-(4-methoxyphenyl)-2-propenoic Acid, Isoamyl Ester
84. 3-methylbutyl (2e)-3-(4-methoxyphenyl)-2-propenoate
85. Brd-k37851352-001-01-0
86. Q17012246
87. Z212714982
88. Amiloxate, United States Pharmacopeia (usp) Reference Standard
89. 2-benzoic Acid, 2-propenoic Acid, 3-(4-methoxyphenyl)-3-methylbutyl Ester
| Molecular Weight | 248.32 g/mol |
|---|---|
| Molecular Formula | C15H20O3 |
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 7 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 35.5 |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 263 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Indicated as an active sunscreen agent.
Absorption
According to _in vitro_ studies of amiloxate-containing tape strips on porcine ear, there was no detection of amiloxate undergoing skin penetration.
Route of Elimination
No pharmacokinetic data available.
Volume of Distribution
No pharmacokinetic data available.
Clearance
No pharmacokinetic data available.
No pharmacokinetic data available.
No pharmacokinetic data available.
Amiloxate is a UV-B filter that selectively absorbs UV-B rays. It is proposed that amiloxate mediates an antioxidant action by acting as a free radical scavenger.
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
44
PharmaCompass offers a list of Amiloxate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Amiloxate manufacturer or Amiloxate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amiloxate manufacturer or Amiloxate supplier.
A Amiloxate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amiloxate, including repackagers and relabelers. The FDA regulates Amiloxate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amiloxate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Amiloxate supplier is an individual or a company that provides Amiloxate active pharmaceutical ingredient (API) or Amiloxate finished formulations upon request. The Amiloxate suppliers may include Amiloxate API manufacturers, exporters, distributors and traders.
Amiloxate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Amiloxate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Amiloxate GMP manufacturer or Amiloxate GMP API supplier for your needs.
A Amiloxate CoA (Certificate of Analysis) is a formal document that attests to Amiloxate's compliance with Amiloxate specifications and serves as a tool for batch-level quality control.
Amiloxate CoA mostly includes findings from lab analyses of a specific batch. For each Amiloxate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Amiloxate may be tested according to a variety of international standards, such as European Pharmacopoeia (Amiloxate EP), Amiloxate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Amiloxate USP).
